Bayer pumping $100M into new hemophilia-focused Berkeley testing facility
- A new $100 million facility in Berkeley, CA will be used to test Bayer's hemophilia A therapies-in-development.
- It will be built on the company's 45-acre manufacturing site in West Berkeley.
- This move is part of Bayer's longstanding commitment to the Bay area, which is its U.S. headquarters for R&D and biotech manufacturing.
As the largest private employer in Berkeley, Bayer, which employs roughly 1,600 people there, uses that manpower to supply hemophilia drugs to 10,000 patients in the U.S. and 400,000 patients globally.
The relationship between Berkeley and Bayer was solidified in 1993 when the two started an organization known as Biotech Partners. This organization trains local students for technical bioscience jobs, and benefits students from Berkeley High School, Oakland Technical High School and Peralta Community College. In addition, the partnership includes government agencies and industry partners.
- berkeleyside.com Bayer invests $100M in new testing facility in Berkeley